GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value'Market Watch • 07/02/21
Activist Fund Elliott Management Wants GlaxoSmithKline Board Shakeup For 'Years Of Under Management'Benzinga • 07/01/21
GlaxoSmithKline's and Vir's Latest COVID Therapy Results: What Investors Should KnowThe Motley Fool • 07/01/21
GlaxoSmithKline called for top management review by activist investor Elliott ManagementProactive Investors • 07/01/21
TUMS® Fuels the Autoburn, a Road Trip to America's Spiciest Destinations, with Hot Food Expert Sean EvansPRNewsWire • 06/29/21
GlaxoSmithKline taps Goldman, Citi to advise on consumer unit spinoff - Bloomberg NewsReuters • 06/25/21
GlaxoSmithKline quells market concerns for now but hard work yet to startProactive Investors • 06/24/21
GlaxoSmithKline: Did CEO's revamp plan pass City muster? One leading bank has its sayProactive Investors • 06/24/21
GSK unveils ambitious growth targets after pressure from activist fund Elliott. But is this enough?Market Watch • 06/23/21